Cita APA

Kimura, H., Sone, T., Araya, T., Murata, A., Yamamura, K., Ohkura, N., . . . Kasahara, K. (2021). Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: A case series. Transl Lung Cancer Res.

Chicago Style Citation

Kimura, Hideharu, Takashi Sone, Tomoyuki Araya, Akari Murata, Kenta Yamamura, Noriyuki Ohkura, Johsuke Hara, Miki Abo, i Kazuo Kasahara. "Late-onset Programmed Cell Death Protein-1 Inhibitor-induced Pneumonitis After Cessation of Nivolumab or Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer: A Case Series." Transl Lung Cancer Res 2021.

Cita MLA

Kimura, Hideharu, et al. "Late-onset Programmed Cell Death Protein-1 Inhibitor-induced Pneumonitis After Cessation of Nivolumab or Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer: A Case Series." Transl Lung Cancer Res 2021.